PM Modi said “Jab tak dabba nahi, tab tak dhilai nahi”.
As per reports, Bharat Biotech’s Covaxin saw robust immune response in animal trials. Astrazeneca sincerely resumed trials in UK.
ICMR study shows,till ‘may 2021’ india may have 64lakh covid-19 cases.
At least seven Indian pharma companies, including Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E, are working to develop a vaccine against coronavirus.